within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BD08_MetforminAndVildagliptin;

model MetforminAndVildagliptin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.85,
    Cl = 7.35e-06,
    adminDuration = 600,
    adminMass = 1050 / 1000000,
    adminCount = 1,
    Vd = 0.116,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.014166666666666666,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>MetforminAndVildagliptin</td></tr><tr><td>ATC code:</td><td>A10BD08</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>1050</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>116</td><td>L</td></tr>
    <tr><td>clearance:</td><td>441</td><td>mL/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Metformin and vildagliptin is a fixed-dose combination medication used in the management of type 2 diabetes mellitus, particularly when monotherapy with either component alone does not provide adequate glycemic control. Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity, while vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin levels, thereby enhancing glucose-dependent insulin secretion.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after a single oral dose of fixed-dose metformin/vildagliptin tablets (typically 50 mg vildagliptin + 1000 mg metformin).</p><h4>References</h4><ol><li><p>He, YL (2012). Clinical pharmacokinetics and pharmacodynamics of vildagliptin. <i>Clinical pharmacokinetics</i> 51(3) 147–162. DOI:<a href=\"https://doi.org/10.2165/11598080-000000000-00000\">10.2165/11598080-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22339447/\">https://pubmed.ncbi.nlm.nih.gov/22339447</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A10BD08 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end MetforminAndVildagliptin;
